A detailed history of Trueblood Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Trueblood Wealth Management, LLC holds 6,347 shares of ABBV stock, worth $1.14 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
6,347
Previous 6,374 0.42%
Holding current value
$1.14 Million
Previous $1.09 Billion 14.66%
% of portfolio
0.63%
Previous 0.62%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$163.84 - $199.33 $4,423 - $5,381
-27 Reduced 0.42%
6,347 $1.25 Billion
Q2 2024

Aug 07, 2024

SELL
$154.79 - $180.76 $51,080 - $59,650
-330 Reduced 4.92%
6,374 $1.09 Billion
Q1 2024

Apr 26, 2024

BUY
$159.82 - $182.1 $12,306 - $14,021
77 Added 1.16%
6,704 $1.22 Billion
Q4 2023

Jan 18, 2024

BUY
$137.6 - $154.97 $911,875 - $1.03 Million
6,627 New
6,627 $1.03 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Trueblood Wealth Management, LLC Portfolio

Follow Trueblood Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trueblood Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trueblood Wealth Management, LLC with notifications on news.